Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 228
Filter
2.
Sci Rep ; 11(1): 10535, 2021 05 18.
Article in English | MEDLINE | ID: mdl-34006977

ABSTRACT

To compare changes in spectral CT iodine densities of hepatic parenchyma and vessels before and after transjugular intrahepatic portosystemic shunt (TIPS) in hepatitis B virus (HBV)-related liver cirrhosis. Twenty-five patients with HBV-related liver cirrhosis who received TIPS for gastroesophageal varices bleeding were recruited. Each patient underwent three phases contrast CT before and after TIPS within 4 weeks, with the raw data reconstructed at 1.25-mm-thick slices. Iodine density (in milligrams per milliliter) was measured on iodine-based material decomposition image. Multiple regions of interest (ROIs) in liver parenchyma, aorta and portal vein were selected from three slices of images. Portal vein trunk was set as the central one, and mean liver parenchymal iodine densities from arterial phase (AP), venous phase (VP) and equilibrium phase (EP) were recorded. Quantitative indices of iodine density (ID), including normalized ID in liver parenchyma for arterial phase (NIDLAP), ID of liver parenchyma for venous phase (IDLVP), ID of portal vein in venous phase (IDPVP) and liver arterial iodine density fraction (AIF), were measured and compared before and after TIPS. Based on Child-Pugh stage, 4, 12 and 9 patients were classified as grade A, B, and C, respectively. Liver volume was comparable before and after TIPS (1110.5 ± 287.4 vs. 1092.0 ± 276.3, P = 0.28). After TIPS, ID was decreased in aorta (146.0 ± 34.5 vs. 120.9 ± 30.7, P < 0.01) whereas increased in liver parenchyma at arterial phase, as demonstrated by IDAP (9.3 ± 3.1 vs. 13.4 ± 4.4 mg/mL) and AIF (0.40 ± 0.11 vs. 0.58 ± 0.11, P < 0.01). For venous or equilibrium phase, quantitative indices remained stable (23.1 ± 4.5 vs. 23.0 ± 5.3, 19.8 ± 4.1 vs. 19.4 ± 4.6) mg/mL (Ps > 0.05). For portal vein, ID and NID were increased after TIPS (23.1 ± 11.7 vs. 36.5 ± 13.0, 16.4 ± 8.5 vs. 31.8 ± 12.8) (P < 0.01). No positive correlation between iodine density and preoperative Child-Pugh score was observed. Based on iodine density measurement, spectral CT as a noninvasive imaging modality may assess hepatic parenchyma and vascular blood flow changes before and after TIPS in HBV-related liver cirrhosis.Clinical registration number: ChiCTR- DDC-16009986.


Subject(s)
Contrast Media , Hepatitis B virus/isolation & purification , Iodides/metabolism , Liver Cirrhosis/diagnostic imaging , Liver/diagnostic imaging , Portasystemic Shunt, Transjugular Intrahepatic/methods , Tomography, X-Ray Computed/methods , Adult , Aged , Female , Humans , Iodides/administration & dosage , Liver/blood supply , Liver/physiopathology , Liver Cirrhosis/physiopathology , Liver Cirrhosis/virology , Male , Middle Aged
3.
Laryngoscope ; 131(9): 2036-2040, 2021 09.
Article in English | MEDLINE | ID: mdl-33729575

ABSTRACT

OBJECTIVES/HYPOTHESIS: Transoral surgery (TOS) has become increasingly popular for patients with superficial hypopharyngeal squamous cell carcinoma (SCC). However, the number of patients in whom metachronous multiple SCC of the head and neck (HNSCC) occurs has also increased. In this study, we investigated whether multiple lugol-voiding lesions (LVLs) in the pharyngeal background mucosa observed during TOS would be a biomarker of metachronous HNSCC. STUDY DESIGN: Retrospective study. METHODS: We examined 362 patients who underwent TOS for superficial hypopharyngeal carcinoma. Endoscopic images were reviewed in a blinded fashion by two endoscopists. LVLs in the pharyngeal mucosa were graded as follows: A, no lesions; B, 1 to 4 lesions; and C, ≥5 lesions per endoscopic view. RESULTS: Cumulative incidence curves of secondary HNSCC in the groups of grades A, B, and C revealed 3-year incidence rates of 14.4%, 18.8%, and 29.3%, respectively (P = .001 for A vs. C and P = .002 for B vs. C). Cumulative incidence curves of third HNSCC in the groups of grades A, B. and C revealed 5-year incidence rates of 3.9%, 9.8%, and 19.6%, respectively (P = .001 for A vs. C and P = .006 for B vs. C). Cumulative incidence curves of fourth HNSCC in the groups of grades A, B, and C revealed 7-year incidence rates of 0%, 2.3%, and 13.2%, respectively (P = .025 for A vs. C and P = .009 for B vs. C). CONCLUSIONS: Multiple LVLs in the pharyngeal mucosa increase the risk of development of metachronous multiple HNSCC. LEVEL OF EVIDENCE: 3 (nonrandomized, controlled cohort/follow-up study) Laryngoscope, 131:2036-2040, 2021.


Subject(s)
Hypopharyngeal Neoplasms/pathology , Mucous Membrane/pathology , Neoplasms, Second Primary/pathology , Squamous Cell Carcinoma of Head and Neck/diagnosis , Aged , Endoscopy/methods , Female , Follow-Up Studies , Humans , Incidence , Iodides/administration & dosage , Male , Middle Aged , Mucous Membrane/surgery , Natural Orifice Endoscopic Surgery/methods , Neoplasm Staging , Neoplasms, Second Primary/classification , Neoplasms, Second Primary/diagnosis , Oral Surgical Procedures/methods , Oral Surgical Procedures/trends , Pharynx/pathology , Prognosis , Retrospective Studies , Risk Assessment , Squamous Cell Carcinoma of Head and Neck/surgery
4.
Sci Rep ; 10(1): 18772, 2020 10 30.
Article in English | MEDLINE | ID: mdl-33128010

ABSTRACT

Up to 40% of congenital diseases present disturbances of brain and craniofacial development resulting in simultaneous alterations of both systems. Currently, the best available method to preclinically visualize the brain and the bones simultaneously is to co-register micro-magnetic resonance (µMR) and micro-computed tomography (µCT) scans of the same specimen. However, this requires expertise and access to both imaging techniques, dedicated software and post-processing knowhow. To provide a more affordable, reliable and accessible alternative, recent research has focused on optimizing a contrast-enhanced µCT protocol using iodine as contrast agent that delivers brain and bone images from a single scan. However, the available methods still cannot provide the complete visualization of both the brain and whole craniofacial complex. In this study, we have established an optimized protocol to diffuse the contrast into the brain that allows visualizing the brain parenchyma and the complete craniofacial structure in a single ex vivo µCT scan (whiceCT). In addition, we have developed a new technique that allows visualizing the brain ventricles using a bilateral stereotactic injection of iodine-based contrast (viceCT). Finally, we have tested both techniques in a mouse model of Down syndrome, as it is a neurodevelopmental disorder with craniofacial, brain and ventricle defects. The combined use of viceCT and whiceCT provides a complete visualization of the brain and bones with intact craniofacial structure of an adult mouse ex vivo using a single imaging modality.


Subject(s)
Brain/diagnostic imaging , Cerebral Ventricles/diagnostic imaging , Contrast Media/administration & dosage , Face/diagnostic imaging , Skull/diagnostic imaging , X-Ray Microtomography/methods , Animals , Blood-Brain Barrier , Brain/anatomy & histology , Cerebral Ventricles/anatomy & histology , Contrast Media/pharmacokinetics , Face/anatomy & histology , Iodides/administration & dosage , Mice , Skull/anatomy & histology
5.
Med Hypotheses ; 143: 109866, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32473509

ABSTRACT

Zinc Iodide and Dimethyl Sulfoxide compositions are proposed as therapeutic agents to treat and prevent chronic and acute viral infections including SARS-CoV-2 infected patients. The therapeutic combinations have a wide range of virucidal effects on DNA and RNA containing viruses. The combinations also exhibit anti-inflammatory, immunomodulating, antifibrotic, antibacterial, antifungal and antioxidative effects. Given the fact that Zinc Iodide has been used as an oral antiseptic agent and DMSO has been already proven as a safe pharmaceutical solvent and therapeutic agent, we hypothesize that the combination of these two agents can be applied as an effective, safe and inexpensive treatment for SARS-CoV-2 and other viral infection. The therapeutic compound can be applied as both etiological and pathogenesis therapy and used as an effective and safe antiseptic (disinfectant) for human and animals as well.


Subject(s)
Coronavirus Infections/drug therapy , Dimethyl Sulfoxide/administration & dosage , Disinfectants/administration & dosage , Iodides/administration & dosage , Pneumonia, Viral/drug therapy , Zinc Compounds/administration & dosage , Animals , Anti-Inflammatory Agents/administration & dosage , Antioxidants/administration & dosage , Antiviral Agents/administration & dosage , Betacoronavirus , COVID-19 , Drug Therapy, Combination , Humans , Inflammation , Pandemics , SARS-CoV-2 , Solvents , Virus Diseases/drug therapy , COVID-19 Drug Treatment
6.
Med Princ Pract ; 29(2): 188-194, 2020.
Article in English | MEDLINE | ID: mdl-31536980

ABSTRACT

OBJECTIVE: This study assessed whether high levels of iodide administered during percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) differentially influenced thyroid function compared to PCI for non-complex coronary lesions. SUBJECTS AND METHODS: A total of 615 patients were enrolled in the study; 205 underwent elective PCI for CTO lesions (Group I) and 410 underwent elective PCI for non-complex lesions including non-CTO, non-bifurcation, non-calcified, and non-tortuous lesions (Group II). Patients were monitored for development of incidental thyroid dysfunction between 1 and 6 months after PCI. RESULTS: The patients in Group I were administered a median of 255 mL of contrast medium during PCI for CTO; a median of 80 mL was administered to the patients in Group II during non-complex PCI (p =0.001). Ten (5.4%) of the 186 euthyroid patients in Group I and 19 (5%) of the 379 eu-thyroid patients in Group II developed subclinical hyper-thyroidism (p = 0.854). However, 7 (50%) of the 14 subclinical hyperthyroid patients in Group I and only 3 (12%) of the 25 subclinical hyperthyroid patients in Group II developed overt hyperthyroidism (p = 0.019). CONCLUSION: In euthyroid patients, PCI for coronary CTO lesions did not increase the risk for subclinical hyperthyroidism when compared to PCI for non-complex coronary lesions. However, in patients with subclinical hyperthyroidism at baseline, PCI for coronary CTO lesions significantly increased the development of overt hyperthyroidism when compared to PCI for non-complex coronary lesions.


Subject(s)
Hyperthyroidism/chemically induced , Hyperthyroidism/epidemiology , Iodides/adverse effects , Percutaneous Coronary Intervention/methods , Thyroid Gland/drug effects , Adult , Aged , Coronary Occlusion/surgery , Female , Humans , Iodides/administration & dosage , Male , Middle Aged , Turkey/epidemiology
7.
Arq Gastroenterol ; 56(1): 41-44, 2019.
Article in English | MEDLINE | ID: mdl-31141072

ABSTRACT

BACKGROUND: Esophageal cancer is the eighth most common cancer. The prognosis is bleak in patients with advanced stages. Patients with early disease have a better prognosis than those with advanced stage. There are several techniques for the screening of premalignant and superficial lesions including chromoendoscopy. OBJECTIVE: This article aimed to determine the effectiveness of chromoendoscopy with toluidine blue combined with Lugol's solution for diagnosis of esophageal premalignant and superficial neoplastic lesions in high risk patients. METHODS: Routine white light upper endoscopy was performed. Toluidine blue was sprayed from the gastroesophageal junction to 20 cm of the dental arch. Then the uptake dye areas were characterized. Later Lugol's solution was sprayed. Areas with less-intense staining were characterized. Biopsy of the toluidine blue capturing areas and areas with less-intense staining of Lugol's solution were taken. In the cases where lesions were not evidenced after application of dyes, biopsies four quadrants of the esophageal mucosa were taken. The samples were evaluated by a digestive pathologist. RESULTS: Barrett's esophagus was the most common premalignant lesion and the early neoplastic lesion was adenocarcinoma with a sensitivity of 100%, specificity 85.7%, positive predictive value 30%, negative predictive value 100%, positive likelihood ratio 7 negative likelihood ratio 0. CONCLUSION: Chromoendoscopy with toluidine blue combined with Lugol's solution is a useful tool in the screening of esophageal premalignant lesions and superficial neoplasms.


Subject(s)
Early Detection of Cancer/methods , Esophageal Neoplasms/diagnostic imaging , Esophagoscopy/methods , Precancerous Conditions/diagnostic imaging , Adult , Barrett Esophagus/diagnostic imaging , Barrett Esophagus/pathology , Coloring Agents/administration & dosage , Cross-Sectional Studies , Esophageal Mucosa/diagnostic imaging , Esophageal Mucosa/pathology , Esophagitis, Peptic/diagnostic imaging , Female , Humans , Iodides/administration & dosage , Male , Middle Aged , Precancerous Conditions/pathology , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity , Tolonium Chloride/administration & dosage
8.
Radiat Prot Dosimetry ; 187(1): 69-76, 2019 Dec 31.
Article in English | MEDLINE | ID: mdl-31135910

ABSTRACT

Iodine thyroid blocking (ITB) suppresses the uptake of iodine to the thyroid and reduces internal doses after radioiodine intake; however, its disturbance of thyroid biokinetics causes considerable uncertainty in the use of dosimetric data intended for assessment of unblocked normal thyroid. To more accurately assess internal dose after ITB, practical dosimetry methods were proposed that consider the ITB effect in a dosimetric manner. A method using the ratio of urine excretion to thyroid retention activity was proposed to retrospectively determine individual-specific ITB levels; bioassay functions and dose coefficients corresponding to ITB levels were calculated separately using the latest biokinetic model and fundamental data. Moreover, insensitive measurement points of time, which led to similar results regardless of ITB level, were determined based on the dose per unit content. Proposed insensitive points for inhalation of vapour forms and particulate forms, respectively, were 1.5 days and 2 days after exposure.


Subject(s)
Iodides/administration & dosage , Iodine Radioisotopes/analysis , Radiation Exposure/analysis , Radiation Monitoring/methods , Radiation Protection/methods , Thyroid Gland/radiation effects , Humans , Iodine Radioisotopes/administration & dosage , Retrospective Studies , Thyroid Gland/drug effects
9.
Arq. gastroenterol ; 56(1): 41-44, Jan.-Mar. 2019. tab, graf
Article in English | LILACS | ID: biblio-1001321

ABSTRACT

ABSTRACT BACKGROUND: Esophageal cancer is the eighth most common cancer. The prognosis is bleak in patients with advanced stages. Patients with early disease have a better prognosis than those with advanced stage. There are several techniques for the screening of premalignant and superficial lesions including chromoendoscopy. OBJECTIVE: This article aimed to determine the effectiveness of chromoendoscopy with toluidine blue combined with Lugol's solution for diagnosis of esophageal premalignant and superficial neoplastic lesions in high risk patients. METHODS: Routine white light upper endoscopy was performed. Toluidine blue was sprayed from the gastroesophageal junction to 20 cm of the dental arch. Then the uptake dye areas were characterized. Later Lugol's solution was sprayed. Areas with less-intense staining were characterized. Biopsy of the toluidine blue capturing areas and areas with less-intense staining of Lugol's solution were taken. In the cases where lesions were not evidenced after application of dyes, biopsies four quadrants of the esophageal mucosa were taken. The samples were evaluated by a digestive pathologist. RESULTS: Barrett's esophagus was the most common premalignant lesion and the early neoplastic lesion was adenocarcinoma with a sensitivity of 100%, specificity 85.7%, positive predictive value 30%, negative predictive value 100%, positive likelihood ratio 7 negative likelihood ratio 0. CONCLUSION: Chromoendoscopy with toluidine blue combined with Lugol's solution is a useful tool in the screening of esophageal premalignant lesions and superficial neoplasms.


RESUMO CONTEXTO: O câncer de esôfago é o oitavo câncer mais comum. O prognóstico é sombrio em pacientes com estágios avançados. Pacientes com doença precoce têm um melhor prognóstico do que aqueles com estágio avançado. Existem várias técnicas para a triagem de lesões pré-malignas e superficiais, incluindo cromoendoscopia. OBJETIVO: Este artigo objetivou determinar a efetividade da cromoendoscopia com azul de toluidina combinada com a solução de Lugol para o diagnóstico de lesões neoplásicas pré-malignas e superficiais esofágicas em pacientes de alto risco. MÉTODOS - A endoscopia de luz branca de rotina foi realizada de forma rotineira. O azul do toluidina foi pulverizado desde a junção gastroesofágica até 20 cm da arcada dentária. As áreas impregnadas pela tintura da tomada foram então caracterizadas. Mais adiante a solução de Lugol foi pulverizada. Áreas com coloração menos intensa foram caracterizadas. Foram realizadas biópsias das áreas de captura de azul de toluidina e áreas com coloração menos intensa da solução de Lugol. Nos casos onde as lesões não foram evidenciadas após a aplicação das tinturas, foram feitas biópsias em quatro quadrantes da mucosa esofágica. As amostras foram avaliadas por um patologista especializado. RESULTADOS: O esôfago de Barrett foi a lesão pré-maligna mais frequente e a lesão neoplásica precoce foi adenocarcinoma com sensibilidade de 100%, especificidade de 85,7%, valor preditivo positivo de 30%, valor preditivo negativo 100%, razão de verossimilhança positiva 7 e razão de verossimilhança negativa 0. CONCLUSÃO: A cromoendoscopia com azul de toluidina combinada com a solução de Lugol é uma ferramenta útil na triagem de lesões pré-malignas esofágicas e neoplasias superficiais.


Subject(s)
Humans , Male , Female , Adult , Precancerous Conditions/diagnostic imaging , Esophageal Neoplasms/diagnostic imaging , Esophagoscopy/methods , Early Detection of Cancer/methods , Precancerous Conditions/pathology , Tolonium Chloride/administration & dosage , Barrett Esophagus/pathology , Barrett Esophagus/diagnostic imaging , Esophagitis, Peptic/diagnostic imaging , Cross-Sectional Studies , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity , Coloring Agents/administration & dosage , Esophageal Mucosa/pathology , Esophageal Mucosa/diagnostic imaging , Iodides/administration & dosage , Middle Aged
11.
Clin Exp Immunol ; 196(1): 52-58, 2019 04.
Article in English | MEDLINE | ID: mdl-30566234

ABSTRACT

NOD.H2h4 mice are the most commonly used model for human autoimmune thyroiditis. Because thyroid autoimmunity develops slowly (over months), NOD.H2h4 mice are usually exposed to excess dietary iodide to accelerate and amplify the process. However, unlike the female bias in human thyroid autoimmunity, autoantibodies to thyroglobulin (TgAb) are reported to be similar in male and female NOD.H2h4 . We sought evidence for sexual dimorphism in other parameters in this strain maintained on regular or iodized water. Without iodide, TgAb levels are higher in males than in females, the reverse of human disease. In humans, autoantibodies to thyroid peroxidase (TPOAb) are a better marker of disease than TgAb. In NOD.H2h4 mice TPOAb develop more slowly than TgAb, being detectable at 6 months of age versus 4 months for the latter. Remarkably, unlike TgAb, TPOAb levels are higher in female than male NOD.H2h4 mice on both regular and iodized water. As previously observed, serum T4 levels are similar in both sexes. However, thyroid-stimulating hormone (TSH) levels are significantly higher in males than females with or without iodide exposure. TSH levels correlate with TgAb levels in male NOD.H2h4 mice, suggesting a possible role for TSH in TgAb development. However, there is no correlation between TSH and TPOAb levels, the latter more important than TgAb in human disease. In conclusion, if the goal of an animal model is to closely reflect human disease, TPOAb rather than TgAb should be measured in older female NOD.H2h4 mice, an approach requiring patience and the use of mouse TPO protein.


Subject(s)
Aging/immunology , Iodide Peroxidase/immunology , Sex Factors , Thyroiditis, Autoimmune/immunology , Animals , Antibody Formation , Autoantibodies/metabolism , Diet Therapy , Disease Models, Animal , Female , Humans , Iodides/administration & dosage , Male , Mice , Mice, Inbred NOD , Sex Characteristics , Thyroglobulin/immunology , Thyroiditis, Autoimmune/diagnosis , Thyrotropin/blood
12.
Crit Care Med ; 46(11): e1063-e1069, 2018 11.
Article in English | MEDLINE | ID: mdl-30063489

ABSTRACT

OBJECTIVES: In this study, we tested whether iodide would reduce heart damage in rat and pig models of acute myocardial infarction as a risk analysis for a human trial. DESIGN: Prospective blinded and randomized laboratory animal investigation. SETTING: Animal research laboratories. SUBJECTS: Sexually mature rats and pigs. INTERVENTIONS: Acute myocardial infarction was induced by temporary ligation of the coronary artery followed by reperfusion. Iodide was administered orally in rats or IV in rats and pigs just prior to reperfusion. MEASUREMENTS AND MAIN RESULTS: Damage was assessed by blood cardiac troponin and infarct size; heart function was determined by echocardiography. Blood peroxide scavenging activity was measured enzymatically, and blood thyroid hormone was determined using radioimmune assay. Iodide administration preserved heart function and reduced blood cardiac troponin and infarct size by approximately 45% in pigs and approximately 60% in rats. Iodide administration also increased blood peroxide scavenging activity and maintained thyroid hormone levels. CONCLUSIONS: Iodide administration improved the structure and function of the heart after acute myocardial infarction in rats and pigs.


Subject(s)
Disease Models, Animal , Iodides/administration & dosage , Myocardial Reperfusion Injury/diagnostic imaging , Myocardial Reperfusion Injury/prevention & control , Animals , Coronary Vessels/drug effects , Echocardiography , Prospective Studies , Random Allocation , Rats , Swine , Thyroid Gland/drug effects
13.
Wei Sheng Yan Jiu ; 47(1): 56-61, 2018 Jan.
Article in Chinese | MEDLINE | ID: mdl-29903225

ABSTRACT

OBJECTIVE: To assess the iodine nutrition and thyroid function of lactatingwomen in different iodine nutrition level of children in Gansu Province, and provide a scientific basis for iodine supplementation. METHODS: Liangzhou district( the median urinary iodine was greater than or equal to 300 g/L), Linze county( the median urinary iodine was from 200 to 299 g/L) and Huating county( the median urinary iodine was from100 to 199 g/L) were selected according to 8-10 years old children urinary iodine in2009. Huating county, Liangzhou district and Linze county were as iodine excessive area, iodine suitable area 1 and iodine suitable area 2, respectively in 2014. One township was randomly selected from the east, west, south, north and middle parts of each research point, 10 lactating women were randomly collected in each township, who was tested urine samples and thyroid function. Salt intake was surveyed in 3 townships. 2 samples were collected in centralized water supplies, 1 sample was collected in its coverage by the east, west, south, north and middle parts; 1 sample was collected by the east, west, south, north and middle parts in decentralized water supplies, which were tested of water iodine. RESULTS: The medians of water iodine were 2. 32, 0. 70 and 6. 18 µg/L and the medians of salt iodine were 25. 3, 25. 0 and 28. 6 mg/kg for iodine excessive area, iodine suitable area 1 and iodine suitable area 2, respectively. Per capita daily intake of salt were 15. 0, 11. 3 and 4. 7 g for iodine excessive area, iodine suitable area 1 and iodine suitable area 2 respectively, there were statisticant differences. The median urinary iodine of lactating women were 181. 8, 143. 1 and 104. 9 µg/L for iodine excessive area, iodine suitable area 1 and iodine suitable area 2, respectively. The medians of thyroidstimulating hormone( TSH) were 2. 3, 2. 2 and 1. 9 mIU/L, mean values of free thyroxine( FT4) were 15. 0, 13. 9 and 14. 6 pmol/L, mean values of free triidothyronine( FT3) were 5. 0, 4. 8 and 4. 6 pmol/L for iodine excessive area, iodine suitable area 1 and iodine suitable area 2 respectively, there were not statistically differences. The positive rate of thyromicrosomal antibody( Tm Ab) were 3. 6 %, 11. 3 % and 13. 2 % and the positive rate of thyroglobulin antibody( Tg Ab) were 3. 6 %, 11. 3 % and 11. 3 % for iodine excessive area, iodine suitable area 1 and iodine suitable area 2 respectively( P >0. 05). Prevalence of thyroid function disorders were 14. 3 %, 21. 0 % and 9. 4 % and prevalence of low-FT4 syndrome were 7. 1 %, 4. 8 % and 1. 9 %, prevalence of subclinical hypothyroidism were 3. 6 %, 11. 3 % and 3. 8 % for iodine excessive area, iodine suitable area 1 and iodine suitable area 2 respectively( P > 0. 05). CONCLUSION: Iodine nutrition level was appropriate for lactating women in 3 areas, but some lactating women were iodine deficiency or iodine excess. There were occurred thyroid function disorders in some lactating women in 3 areas. The lactating women's iodine nutrition and thyroid function should be monitored and the normal reference value of thyroid function on lactating women should be established also.


Subject(s)
Iodides/blood , Iodine/administration & dosage , Iodine/urine , Lactation , Thyroid Gland/physiology , Adult , Child , China/epidemiology , Cross-Sectional Studies , Female , Humans , Iodides/administration & dosage , Middle Aged , Thyroid Function Tests , Thyrotropin/blood , Thyroxine/blood
14.
Zhonghua Liu Xing Bing Xue Za Zhi ; 39(5): 609-613, 2018 May 10.
Article in Chinese | MEDLINE | ID: mdl-29860803

ABSTRACT

Objective: To investigate the effects of high iodine intake on thyroid function in pregnant and lactating women. Methods: A cross sectional epidemiological study was conducted among 130 pregnant women and 220 lactating women aged 19-40 years in areas with high environment iodine level (>300 µg/L) or proper environment iodine level (50-100 µg/L) in Shanxi in 2014. The general information, urine samples and blood samples of the women surveyed and water samples were collected. The water and urine iodine levels were detected with arsenic and cerium catalysis spectrophotometric method, the blood TSH level was detected with electrochemiluminescence immunoassay, and thyroid stimulating hormone (FT(4)), antithyroid peroxidase autoantibody (TPOAb) and anti-thyroglobulin antibodies (TGAb) were detected with chemiluminescence immunoassay. Results: The median urine iodine levels of the four groups were 221.9, 282.5, 814.1 and 818.6 µg/L, respectively. The median serum FT(4) of lactating women in high iodine area and proper iodine area were 12.96 and 13.22 pmol/L, and the median serum TSH was 2.45 and 2.17 mIU/L, respectively. The median serum FT(4) of pregnant women in high iodine area and proper iodine area were 14.66 and 16.16 pmol/L, and the median serum TSH was 2.13 and 1.82 mIU/L, respectively. The serum FT(4) levels were lower and the abnormal rates of serum TSH were higher in lactating women than in pregnant women in both high iodine area and proper iodine area, the difference was statistically significant (FT(4): Z=-6.677, -4.041, P<0.01; TSH: Z=8.797, 8.910, P<0.01). In high iodine area, the abnormal rate of serum FT(4) in lactating women was higher than that in pregnant women, the difference was statistically significant (Z=7.338, P=0.007). The serum FT(4) level of lactating women in high iodine area was lower than that in proper iodine area, the difference was statistically significant (Z=-4.687, P=0.000). In high iodine area, the median serum FT(4) in early pregnancy, mid-pregnancy and late pregnancy was 16.26, 14.22 and 14.80 pmol/L, respectively, and the median serum TSH was 1.74, 1.91 and 2.38 mIU/L, respectively. In high iodine area, the serum FT(4) level in early pregnancy was higher than that in mid-pregnancy and late pregnancy, and the serum TSH level was lower than that in mid-pregnancy and late pregnancy, the difference was statistically significant (FT(4): Z=-2.174, -2.238, P<0.05; TSH: Z=-2.985, -1.978, P<0.05). There were no significant differences in the positive rates of serum thyroid autoantibodies among the four groups of women and women in different periods of pregnancy (P>0.05). The morbidity rates of subclinical hyperthyroidism in pregnant women and lactating women in high iodine area were obviously higher than those in proper iodine areas, the difference was statistically significant (χ(2)=5.363, 5.007, P<0.05). Conclusions: Excessive iodine intake might increase the risk of subclinical hypothyroidism in pregnant women and lactating women. It is suggested to strengthen the iodine nutrition and thyroid function monitoring in women, pregnant women and lactating women in areas with high environmental iodine.


Subject(s)
Hypothyroidism/epidemiology , Iodides/administration & dosage , Iodine , Lactation , Pregnancy , Thyroid Diseases/epidemiology , Thyroid Gland/physiology , Adult , China/epidemiology , Cross-Sectional Studies , Female , Humans , Iodine/urine , Nutritional Status , Prevalence , Thyroid Function Tests , Young Adult
15.
Am J Gastroenterol ; 113(6): 855-862, 2018 06.
Article in English | MEDLINE | ID: mdl-29748564

ABSTRACT

BACKGROUND: Achalasia patients with longstanding disease are considered to be at risk for developing esophageal cancer. Endoscopic screening is not standardized and detection of dysplastic lesions is difficult, for which Lugol chromoendoscopy could be helpful. Aim was to evaluate the efficacy of screening for esophageal dysplasia and carcinoma in patients with longstanding achalasia using Lugol chromoendoscopy. METHODS: In this cohort study achalasia patients underwent three-annual screening by Lugol chromoendoscopy between January 2000 and March 2016. Patients with low-grade dysplasia (LGD) underwent yearly screening, patients with high-grade dysplasia (HGD) or carcinoma were treated. RESULTS: In total, 230 achalasia patients (144 male, median age 52 years (IQR 43-63) at first endoscopy) were included. Three patients (1.3%, 2 male, age 68 years (range 50-87)) developed esophageal squamous cell carcinoma (ESCC), without LGD at the preceding screening. Incidence rate for ESCC was 63 (95% CI 13-183) per 100 000 persons-years. LGD was observed in 4 patients (1.7%, 2 male, age 64 years (range 57-73)), without progression to HGD/ESCC during a follow-up of 9 (IQR 7-14) years. ESCC/LGD was diagnosed 30 (IQR 14-36) years after onset of symptoms and 22 (IQR 4-13) years after diagnosis. Lugol chromoendoscopy tripled the detection rate of suspected lesions (111 lesions white light versus 329 lesions Lugol), but only 8% was histopathological confirmed ESCC or LGD. CONCLUSION: Achalasia patients with longstanding disease (>20 years) have an increased risk to develop esophageal dysplasia and carcinoma. Endoscopic screening using white light and Lugol chromoendoscopy does not accurately identify precursor lesions for ESCC and therefore cannot be systematically recommended.


Subject(s)
Esophageal Achalasia/pathology , Esophageal Neoplasms/diagnostic imaging , Esophageal Squamous Cell Carcinoma/diagnostic imaging , Esophagoscopy/methods , Precancerous Conditions/pathology , Adult , Aged , Coloring Agents/administration & dosage , Esophageal Achalasia/diagnostic imaging , Esophageal Neoplasms/epidemiology , Esophageal Neoplasms/pathology , Esophageal Squamous Cell Carcinoma/epidemiology , Esophageal Squamous Cell Carcinoma/pathology , Esophagus/diagnostic imaging , Esophagus/pathology , Female , Follow-Up Studies , Humans , Incidence , Iodides/administration & dosage , Light , Male , Mass Screening/methods , Middle Aged , Netherlands/epidemiology , Precancerous Conditions/diagnostic imaging , Prospective Studies , Risk Factors , Time Factors
16.
Biol Trace Elem Res ; 182(2): 231-237, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28770411

ABSTRACT

Many studies focused on the association between thyroid disease and pregnancy outcomes. The present study explored the effect of iodine nutrition during the first trimester on pregnancy outcomes. One thousand five hundred sixty-nine pregnant, euthyroid women at ≤12 weeks of gestation in an iodine-sufficient area in China were recruited. According to the World Health Organization (WHO) criteria for iodine nutrition during pregnancy, participants were divided into four groups: adequate iodine (median urinary iodine concentration (UIC), 150-249 µg/L), mild deficiency (UIC, 100-150 µg/L), moderate and severe deficiency (UIC, <100 µg/L), and more than adequate and excessive (UIC, ≥250 µg/L) groups. Pregnancy outcomes, including abortion, gestational hypertension, pre-eclampsia, gestational diabetes mellitus (GDM), placenta previa, placental abruption, preterm labor, low birth weight infants, macrosomia, breech presentation, and cord entanglement, were obtained during follow-up. The results showed that there was no significant difference in general characteristics, including age, body mass index, abdominal circumference, systolic blood pressure, diastolic blood pressure, heart rate, smoking rate, and drinking rate, among the four groups. In the more than adequate and excessive group, thyroid-stimulating hormone (TSH) was greater and free thyroxine (FT4) was lower than any other groups but still within normal range. The thyroglobulin (Tg) level was greater in the moderate and severe deficiency group. The incidence of GDM was significantly greater in women with mild iodine deficiency than in women with adequate iodine nutriture (18.38 vs. 13.70%, p < 0.05). Compared with the adequate group, incidence of macrosomia was significantly greater in the more than adequate and excessive group (12.42 vs. 9.79%, p < 0.05). Mild iodine deficiency was an independent risk factor for GDM (odds ratio = 1.566, 95% confidence interval = 1.060-2.313, p = 0.024); more than adequate and excessive iodine was an independent risk factor for macrosomia (OR = 1.917, CI = 1.128-3.256, p = 0.016). In summary, during 1st trimester, both mild iodine deficiency and excessive iodine intake had adverse impacts on pregnancy outcomes in an iodine-sufficient area.


Subject(s)
Iodides/administration & dosage , Iodine/administration & dosage , Nutritional Status , Pregnancy Outcome , Adolescent , Adult , Asian People , China , Diabetes, Gestational/ethnology , Diabetes, Gestational/urine , Female , Humans , Infant, Newborn , Iodides/urine , Iodine/deficiency , Iodine/urine , Middle Aged , Pregnancy , Pregnancy Trimester, First/ethnology , Pregnancy Trimester, First/urine , Young Adult
17.
BJOG ; 125(5): 545-553, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28603909

ABSTRACT

BACKGROUND: Visual inspection of the cervix with acetic acid (VIA) or with Lugol's iodine (VILI) have been evaluated for cervical cancer screening in developing countries. OBJECTIVES: To assess the diagnostic accuracy and clinical utility of visual methods to detect cervical intraepithelial neoplasia grade 2+ (CIN2+) using: (1) VIA alone; (2) VILI alone; (3) co-testing; and (4) VILI as a triage test of a positive VIA result. SEARCH STRATEGY: PubMed, EMBASE, and the Cochrane Library were searched up to May 2016. SELECTION CRITERIA: All reports on the accuracy of VIA and VILI, or combinations of VIA/VILI, to detect CIN2+ were identified. Histology and colposcopy when no biopsy was taken were used as the reference standard. DATA COLLECTION AND ANALYSIS: Selected studies were scored on methodological quality, and sensitivity and specificity were computed. Clinical utility was assessed from the positive predictive value (PPV) and the complement of the negative predictive value (cNPV). MAIN RESULTS: We included 23 studies comprising 101 273 women. The pooled sensitivity and specificity of VILI was 88 and 86%, respectively. VILI was more sensitive, but not less specific, compared with VIA (relative sensitivity = 1.11; 95% confidence interval, 95% CI, 1.06-1.16; relative specificity = 0.98; 95% CI 0.95-1.01). Co-testing was hardly more sensitive, but significantly less specific, than VILI alone. VILI to triage VIA-POSITIVE women was not less sensitive, but more specific, compared with VIA alone (relative sensitivity = 0.98, 95% CI 0.96-1.01; relative specificity = 1.04, 95% CI 1.02-1.05). The average PPVs were low (range 11-16%), whereas the cNPV varied between 0.3% (VILI, co-testing) and 0.6% (triage). CONCLUSIONS: Although imperfect, VILI alone appeared to be the most useful visual screening strategy. TWEETABLE ABSTRACT: VILI alone seems to be the most useful visual screening test for cervical cancer screening.


Subject(s)
Acetic Acid/administration & dosage , Indicators and Reagents/administration & dosage , Iodides/administration & dosage , Physical Examination/statistics & numerical data , Uterine Cervical Dysplasia/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Cervix Uteri/pathology , Colposcopy/statistics & numerical data , Early Detection of Cancer/methods , Early Detection of Cancer/statistics & numerical data , Female , Humans , Middle Aged , Physical Examination/methods , Predictive Value of Tests , Sensitivity and Specificity , Uterine Cervical Neoplasms/diagnosis , Young Adult
18.
Biomed Res Int ; 2017: 6302869, 2017.
Article in English | MEDLINE | ID: mdl-29250546

ABSTRACT

Iodine is an important micronutrient required for nutrition. Excess iodine has adverse effects on thyroid, but there is not enough information regarding its effect on salivary glands. In addition to food and iodized salt, skin disinfectants and maternal nutritional supplements contain iodide, so its intake could be excessive during pregnancy, lactation, and infancy. The aim of this work was to evaluate the effect of excess iodide ingestion on salivary glands during mating, gestation, lactation, and postweaning period in mouse. During assay, mice were allocated into groups: control and treatment groups (received distilled water with NaI 1 mg/mL). Water intake, glandular weight, and histology were analyzed. Treatment groups showed an increase in glandular weight and a significantly (p < 0.05) higher water intake than control groups. Lymphocyte infiltration was observed in animals of treatment groups, while there was no infiltration in glandular sections of control groups. Results demonstrated that a negative relationship could exist between iodide excess and salivary glands. This work is novel evidence that high levels of iodide intake could induce mononuclear infiltration in salivary glands. These results should be considered, especially in pregnant/lactating women, to whom a higher iodine intake is usually recommended.


Subject(s)
Iodides/pharmacology , Salivary Glands/drug effects , Animals , Drinking/drug effects , Female , Iodides/administration & dosage , Male , Mice , Organ Size , Pregnancy , Salivary Glands/pathology
19.
Virol J ; 14(1): 168, 2017 09 02.
Article in English | MEDLINE | ID: mdl-28865454

ABSTRACT

BACKGROUND: Cationic derivatives of polyprenols (trimethylpolyprenylammonium iodides - PTAI) with variable chain length between 6 and 15 isoprene units prepared from naturally occurring poly-cis-prenols were tested as DNA vaccine carriers in chickens and mice. This study aimed to investigate if PTAI could be used as an efficient carrier of a DNA vaccine. METHODS: Several vaccine mixtures were prepared by combining different proportions of the vaccine plasmid (carrying cDNA encoding a vaccine antigen, hemagglutinin from H5N1 influenza virus) and various compositions of PTAI. The vaccines were delivered by intramuscular injection to either chickens or mice. The presence of specific antibodies in sera collected from the immunized animals was analyzed by enzyme-linked immunosorbent assay (ELISA) and hemagglutination inhibition (HI) test. RESULTS: The mixtures of PTAI with helper lipids, such as DOPE (1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine), DC-cholesterol [{3ß-[N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol} hydrochloride] or DOPC (1,2-dioleoyl-sn-glycero-3-phosphatidylcholine) induced strong humoral response to the antigen encoded by the DNA vaccine plasmid. CONCLUSION: The animal immunization results confirmed that PTAI compositions, especially mixtures of PTAI with DOPE and DC-cholesterol, do work as effective carriers of DNA vaccines, comparable to the commercially available lipid transfection reagent.


Subject(s)
Drug Delivery Systems , Immunity, Humoral/immunology , Influenza Vaccines/immunology , Vaccination/methods , Vaccines, DNA/immunology , Ammonium Compounds/administration & dosage , Ammonium Compounds/chemistry , Animals , Antibodies, Viral/blood , Cations/chemistry , Chickens , Disease Models, Animal , Female , Influenza Vaccines/administration & dosage , Iodides/administration & dosage , Iodides/chemistry , Male , Mice , Mice, Inbred BALB C , Quaternary Ammonium Compounds/administration & dosage , Quaternary Ammonium Compounds/chemistry , Vaccines, DNA/administration & dosage
20.
Sci Rep ; 7(1): 5329, 2017 07 13.
Article in English | MEDLINE | ID: mdl-28706256

ABSTRACT

The sodium/iodide symporter (NIS) mediates active iodide (I-) accumulation in the thyroid, the first step in thyroid hormone (TH) biosynthesis. Mutations in the SLC5A5 gene encoding NIS that result in a non-functional protein lead to congenital hypothyroidism due to I- transport defect (ITD). ITD is a rare autosomal disorder that, if not treated promptly in infancy, can cause mental retardation, as the TH decrease results in improper development of the nervous system. However, in some patients, hypothyroidism has been ameliorated by unusually large amounts of dietary I-. Here we report the first NIS knockout (KO) mouse model, obtained by targeting exons 6 and 7 of the Slc5a5 gene. In NIS KO mice, in the thyroid, stomach, and salivary gland, NIS is absent, and hence there is no active accumulation of the NIS substrate pertechnetate (99mTcO4-). NIS KO mice showed undetectable serum T4 and very low serum T3 levels when fed a diet supplying the minimum I- requirement for rodents. These hypothyroid mice displayed oxidative stress in the thyroid, but not in the brown adipose tissue or liver. Feeding the mice a high-I- diet partially rescued TH biosynthesis, demonstrating that, at high I- concentrations, I- enters the thyroid through routes other than NIS.


Subject(s)
Dietary Supplements , Hypothyroidism/prevention & control , Iodides/administration & dosage , Symporters/deficiency , Animals , Biological Transport , Disease Models, Animal , Iodides/metabolism , Mice, Knockout , Thyroid Hormones/blood , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...